Can I take Ubrelvy (ubrogepant) together with a triptan?

Can You Take Ubrelvy with a Triptan?

Yes, you can safely take Ubrelvy (ubrogepant) with a triptan—there are no safety concerns with this combination, and it is well-tolerated based on both FDA drug interaction data and clinical trial evidence.

Safety Evidence

The FDA label for Ubrelvy explicitly states that no significant pharmacokinetic interactions were observed when ubrogepant was administered with sumatriptan 1. This means neither drug significantly affects the blood levels or effectiveness of the other in a clinically meaningful way.

A dedicated Phase 1 pharmacokinetic study confirmed this safety profile 2:

• When ubrogepant 100 mg and sumatriptan 100 mg were co-administered, there were minor timing changes (delayed absorption) but no clinically significant alterations in drug exposure
• Zero treatment-emergent adverse events occurred with the combination in healthy volunteers
• Phase 3 trial data showed similar adverse event rates whether patients took ubrogepant alone (14.9%) or ubrogepant plus a triptan as rescue medication (12.8%)

Clinical Context: When This Combination Makes Sense

The 2025 American College of Physicians guideline positions these medications sequentially rather than simultaneously 3:

Standard treatment algorithm:

1. Start with NSAID or acetaminophen at adequate doses
2. If insufficient relief → add a triptan to the NSAID/acetaminophen
3. If triptan combination fails → consider gepants like ubrogepant as an alternative

However, the combination scenario arises in real-world practice when:

• A patient takes a triptan first but needs additional relief 2-24 hours later
• A patient on preventive therapy needs acute treatment (both can be used)
• Switching between medications during the same migraine attack

Important Caveats

Avoid using both simultaneously as first-line treatment. The guideline recommends gepants like ubrogepant specifically for patients who "do not tolerate or have inadequate response to combination therapy of a triptan and an NSAID or acetaminophen" 3. This positions ubrogepant as an alternative to triptans, not routinely combined with them.

Medication overuse headache risk: Be mindful that triptans carry a threshold of ≥10 days per month for medication overuse headache, while gepants appear less likely to cause this complication 3. Using both classes increases the total days of acute medication use.

Drug interactions to monitor: While ubrogepant and triptans don't interact with each other, ubrogepant has significant interactions with strong CYP3A4 inhibitors (avoid with ketoconazole) and inducers (reduced efficacy with rifampin) 1.

Practical Recommendation

If you've taken a triptan and need additional relief, taking ubrogepant is safe. The combination has been studied and poses no cardiovascular or other safety concerns. However, work with your provider to optimize your acute treatment strategy—if you're frequently needing both medications, you may benefit from switching entirely to ubrogepant or considering preventive therapy rather than routinely combining acute treatments.